Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
Medical Countermeasures Seasonal Flu Shots Miss the Mark on Bird Flu ProtectionGlobal Biodefense StaffJune 3, 2025
Medical Countermeasures Universal Vaccines: Broad Protection Meets Economic RealityGlobal Biodefense StaffMay 25, 2025
GSK Announces Plans to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021 Industry News May 28, 2020 …
A Novel Method to Precisely Deliver Therapeutics Inside the Body Medical Countermeasures May 23, 2020 …
Antibodies from SARS Patient Blocks SARS and SARS-CoV-2 in Lab Medical Countermeasures May 23, 2020 …
First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response Medical Countermeasures May 22, 2020 …
Large Observational Study Shows No Benefit for Hydroxychloroquine in COVID-19 Patients Medical Countermeasures May 22, 2020 …
Macaques Show Protective Immunity Against SARS-Cov-2 After Infection or Vaccine Medical Countermeasures May 20, 2020 …
COVID-19 Cytokine Storm: Possible Mechanism for the Deadly Respiratory Syndrome Medical Countermeasures May 20, 2020 …
The Challenges of Developing a Safe and Effective COVID-19 Vaccine Medical Countermeasures May 12, 2020 …
NAU Launches Testing Service Center to Evaluate COVID-19 Drug Candidates Medical Countermeasures May 9, 2020 …
NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding Contracts + Grants May 7, 2020 …
Inactivated Vaccine Candidate Protects Macaques From SARS-Cov-2 Infection Medical Countermeasures May 6, 2020 …
NYU Langone Health Enrolling Patients in US Clinical Trial For COVID-19 mRNA Vaccine Medical Countermeasures May 5, 2020 …
Hydroxychloroquine Linked to Increased Risk of Cardiac Arrhythmia Medical Countermeasures May 1, 2020 …
Pharmacists Warn Against Malarial Drugs as a Cure for Coronavirus Medical Countermeasures April 30, 2020 …
NUS-Led Team Develops Artificial Intelligence Platform to Combat Infectious Diseases Medical Countermeasures April 27, 2020 …
Emergex and GMU’s National Center for Biodefense and Infectious Diseases Partner for Highly Pathogenic RNA Virus Studies Industry News April 22, 2020 …
